绩优基金二季度加仓科技医药板块

Core Insights - The latest disclosures of fund performance reports for Q2 2025 reveal that many high-performing funds maintained a high level of investment during the volatile market conditions [1] - These funds have notably increased their positions in the technology and pharmaceutical sectors [1] - Fund managers are generally optimistic about the value of equity assets and believe there are numerous structural opportunities to capitalize on in the future [1]